Literature DB >> 4370235

Ocular manifestations of the mucopolysaccharidoses.

J François.   

Abstract

Mesh：

Year:  1974        PMID： 4370235     DOI： 10.1159/000307137

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN： 0030-3755            Impact factor:   3.250


× No keyword cloud information.
  6 in total

1.  Glaucoma in siblings with Morquio syndrome.

Authors:  M Cahane; G Treister; F A Abraham; S Melamed
Journal:  Br J Ophthalmol       Date:  1990-06       Impact factor: 4.638

Review 2.  Optic atrophies in metabolic disorders.

Authors:  Marjan Huizing; Brian P Brooks; Yair Anikster
Journal:  Mol Genet Metab       Date:  2005-09-27       Impact factor: 4.797

3.  Morphologic and biochemical studies of canine mucopolysaccharidosis I.

Authors:  R M Shull; R G Helman; E Spellacy; G Constantopoulos; R J Munger; E F Neufeld
Journal:  Am J Pathol       Date:  1984-03       Impact factor: 4.307

4.  Biochemical and histopathological studies on patients with mucopolysaccharidoses, two of whom had been treated by fibroblast transplantation.

Authors:  J Crow; D A Gibbs; W Cozens; E Spellacy; R W Watts
Journal:  J Clin Pathol       Date:  1983-04       Impact factor: 3.411

5.  The pathology of the feline model of mucopolysaccharidosis I.

Authors:  M E Haskins; G D Aguirre; P F Jezyk; R J Desnick; D F Patterson
Journal:  Am J Pathol       Date:  1983-07       Impact factor: 4.307

6.  Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease.

Authors:  Maurizio Scarpa; Zsuzsanna Almássy; Michael Beck; Olaf Bodamer; Iain A Bruce; Linda De Meirleir; Nathalie Guffon; Encarna Guillén-Navarro; Pauline Hensman; Simon Jones; Wolfgang Kamin; Christoph Kampmann; Christina Lampe; Christine A Lavery; Elisa Leão Teles; Bianca Link; Allan M Lund; Gunilla Malm; Susanne Pitz; Michael Rothera; Catherine Stewart; Anna Tylki-Szymańska; Ans van der Ploeg; Robert Walker; Jiri Zeman; James E Wraith
Journal:  Orphanet J Rare Dis       Date:  2011-11-07       Impact factor: 4.123
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.